Lu Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lu Yu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Li Wei
Department of dermatology, Beijing Children's Hospital, National Center for Children's Health Capital Medical University Beijing China
5 shared publications- Lin Ma
Department of Dermatology, Beijing Children’s Hospital, Capital Medical University, Beijing, P.R. China
4 shared publications Li Li
Department of Dermatology, Beijing Children's Hospital National Center for Children's Health, Capital Medical University Beijing China
2 shared publications- Li Li
Department of Dermatology Beijing Children's Hospital, Capital Medical University, National Center for Children's Health Beijing China
2 shared publications Lin Ma
Department of dermatology, Beijing Children's Hospital, National Center for Children's Health Capital Medical University Beijing China
2 shared publicationsXiaofeng Han
Department of Dermatology, Beijing Children's Hospital National Center for Children's Health, Capital Medical University Beijing China
2 shared publications
Latest Publications
- 14 March 2024
- Published by Wiley in Experimental Dermatology
- Vol. 33 (3) , e15053
First report of propranolol treating papillary endovascular angioendothelioma, a promising treatment
- 14 March 2024
- Published by Wiley in Experimental Dermatology
- Vol. 33 (3) , e15053
First report of propranolol treating papillary endovascular angioendothelioma, a promising treatment
- Open Access
- 10 January 2024
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 45, 103970
Inflammatory linear verrucous epidermal nevus in groin and labia with claudication: Successfully treated with photodynamic therapy
- 10 January 2024
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 45, 103970
Open AccessInflammatory linear verrucous epidermal nevus in groin and labia with claudication: Successfully treated with photodynamic therapy
- Open Access
- 14 June 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (12) , 3369-3374
Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment
Introduction: Infantile hepatic hemangioma (IHH) is a common liver tumor in infants and shares the same characteristics as cutaneous infantile hemangioma (IH). Propranolol is effective for symptomatic IHH. The clinical features between cutaneous IH and IHH, and treatment efficacy of IHH (smaller than 4 cm) is unclear. To evaluate the correlation of clinical features between cutaneous IH and IHH, as well as efficacy of systemic propranolol in the treatment of cutaneous IH combined with IHH. Materials and Methods: The clinical data of infants with complicated cutaneous IH combined with IHH treated with systemic propranolol (1.5 similar to 2 mg/(kg d)) from January 2011 to October 2020 were retrospectively analyzed. Results: Forty-five cases with IHH combined with complicated cutaneous IH were reviewed. Single cutaneous IH is more likely to be combined with focal IHH, cutaneous IH greater than 5, more likely to be combined with multiple IHH (Pearson = 0.546, p < 0.01). The mean age of focal and multiple IHH regression was 11.93 +/- 14.42 months and 10.20 +/- 9.15 months, respectively. Conclusions: The number of cutaneous IH were correlated with the number of IHH. There was no difference in the age of complete remission for focal and multiple IHH.
- 14 June 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (12) , 3369-3374
Open AccessClinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment
Introduction: Infantile hepatic hemangioma (IHH) is a common liver tumor in infants and shares the same characteristics as cutaneous infantile hemangioma (IH). Propranolol is effective for symptomatic IHH. The clinical features between cutaneous IH and IHH, and treatment efficacy of IHH (smaller than 4 cm) is unclear. To evaluate the correlation of clinical features between cutaneous IH and IHH, as well as efficacy of systemic propranolol in the treatment of cutaneous IH combined with IHH. Materials and Methods: The clinical data of infants with complicated cutaneous IH combined with IHH treated with systemic propranolol (1.5 similar to 2 mg/(kg d)) from January 2011 to October 2020 were retrospectively analyzed. Results: Forty-five cases with IHH combined with complicated cutaneous IH were reviewed. Single cutaneous IH is more likely to be combined with focal IHH, cutaneous IH greater than 5, more likely to be combined with multiple IHH (Pearson = 0.546, p < 0.01). The mean age of focal and multiple IHH regression was 11.93 +/- 14.42 months and 10.20 +/- 9.15 months, respectively. Conclusions: The number of cutaneous IH were correlated with the number of IHH. There was no difference in the age of complete remission for focal and multiple IHH.
- 10 December 2022
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (4) , E123-E124
First report of oral atenolol for treatment of kaposiform hemangioendothelioma, a viable alternative to propranolol
- 10 December 2022
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (4) , E123-E124
First report of oral atenolol for treatment of kaposiform hemangioendothelioma, a viable alternative to propranolol
- Open Access
- 14 November 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (2) , 696-697
A 6‐year‐old girl with hemangioma with hearing loss in right ear
- 14 November 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (2) , 696-697
Open AccessA 6‐year‐old girl with hemangioma with hearing loss in right ear
- 31 December 2021
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 15 (2) , 237-242
Safety assessment of propranolol for infantile hemangioma: a study in an Asian population
To evaluate the safety of initiating and maintaining propranolol therapy for infantile hemangioma (IH) and the safety of different doses.The retrospective analysis included 336 consecutive cases of...
- 31 December 2021
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 15 (2) , 237-242
Safety assessment of propranolol for infantile hemangioma: a study in an Asian population
To evaluate the safety of initiating and maintaining propranolol therapy for infantile hemangioma (IH) and the safety of different doses.The retrospective analysis included 336 consecutive cases of...
- 25 May 2020
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 33 (1) , 494-497
Comparison and evaluation of three techniques for treating auricular pseudocyst
Background: Auricular pseudocyst is a benign cystic lesion in cartilages of the auricle. Different methods are currently used to manage this disease. In these methods, simple aspiration combined with pressure dressing, local steroid injection and surgery are the most prevalent therapies. Objective: To find the best clinical path for the treatment of auricular pseudocyst. Methods: Eighty-four subjects were randomly allocated into three equal groups (Group A: simple suction combined with pressure dressing; Group B: suction and local steroid injection; and, Group C: surgery). Two otolaryngologists assessed effective rate, sequelae and degree of satisfaction at three-month follow-up. A visual analog scale was used to determine degree of satisfaction. Results: Group A had the lowest effective rate (54%). Group C was highest in terms of effectiveness (100%) but also in incidence of sequelae (71%). Group B had a slightly lower effective rate (86%) than Group C, but the incidence of sequelae was lowest (42%). Degree of satisfaction was highest (7.0 ± 2.7) for Group B. Conclusion: Local steroid injection should be the first choice for the treatment of auricular pseudocyst because of high satisfaction, favorable effectiveness and few sequelae. Where this method is ineffective, surgery should be used.
- 25 May 2020
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 33 (1) , 494-497
Comparison and evaluation of three techniques for treating auricular pseudocyst
Background: Auricular pseudocyst is a benign cystic lesion in cartilages of the auricle. Different methods are currently used to manage this disease. In these methods, simple aspiration combined with pressure dressing, local steroid injection and surgery are the most prevalent therapies. Objective: To find the best clinical path for the treatment of auricular pseudocyst. Methods: Eighty-four subjects were randomly allocated into three equal groups (Group A: simple suction combined with pressure dressing; Group B: suction and local steroid injection; and, Group C: surgery). Two otolaryngologists assessed effective rate, sequelae and degree of satisfaction at three-month follow-up. A visual analog scale was used to determine degree of satisfaction. Results: Group A had the lowest effective rate (54%). Group C was highest in terms of effectiveness (100%) but also in incidence of sequelae (71%). Group B had a slightly lower effective rate (86%) than Group C, but the incidence of sequelae was lowest (42%). Degree of satisfaction was highest (7.0 ± 2.7) for Group B. Conclusion: Local steroid injection should be the first choice for the treatment of auricular pseudocyst because of high satisfaction, favorable effectiveness and few sequelae. Where this method is ineffective, surgery should be used.